Acorah Software Products - Accounts Production 16.8.200 false true false true No description of principal activity 26 May 2024 31 May 2025 31 May 2025 15743280 Dr Stephen Smith Dr Maria Vella iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15743280 2024-05-25 15743280 2025-05-31 15743280 2024-05-26 2025-05-31 15743280 frs-core:CurrentFinancialInstruments 2025-05-31 15743280 frs-bus:PrivateLimitedCompanyLtd 2024-05-26 2025-05-31 15743280 frs-bus:FilletedAccounts 2024-05-26 2025-05-31 15743280 frs-bus:Micro-entities 2024-05-26 2025-05-31 15743280 frs-bus:AuditExempt-NoAccountantsReport 2024-05-26 2025-05-31 15743280 frs-bus:Director1 2024-05-26 2025-05-31 15743280 frs-bus:Director2 2024-05-26 2025-05-31
Registered number: 15743280
Elevate Medtech Ltd.
Unaudited Financial Statements
For The Year Ended 31 May 2025
Elevate Medtech Ltd.
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 15743280

| 2025
--- | ---
|  | £
Current assets |  | 1,415
Creditors: Amounts Falling Due Within One Year |  | (717 )
NET CURRENT ASSETS |  | 698
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 698
Accruals and deferred income |  | (299 )
NET ASSETS |  | 399
CAPITAL AND RESERVES |  | 399

## Notes

1. General Information
Elevate Medtech Ltd. is a private company, limited by shares, incorporated in England & Wales, registered number 15743280 . The registered office is Fourwinds Ipswich Road, Rougham, Bury St. Edmunds, IP30 9LZ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Stephen Smith Director
23rd January 2026